Envista appoints Stryker executive J. Andrew Pierce to Board, adds Audit Committee role

Envista Holdings Corp

J. Andrew Pierce elected to Board effective July 14, 2025, expanding Board from 8 to 9 members.
Pierce is Group President, MedSurg & Neurotechnology at Stryker since 2019; 29-year Stryker veteran.
Pierce joins Audit Committee; Board committee composition updated accordingly.
He will receive standard non-employee director compensation, pro-rated for FY2025, plus equity awards and indemnification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.